NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-55 Cr | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-7.48 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-2.80 Cr |
| Mar2021 | ₹-12 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-7.48 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-2.80 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹333.5 Cr | -6.2% | 2.8% | -64.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,287.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,657.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,202.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,276.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,024.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -6.2% |
2.8% |
-64.3% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses